Amy S.F. Lutz is a historian of medicine at the University of Pennsylvania in Philadelphia, vice president of the National Council on Severe Autism and the parent of a profoundly autistic son, Jonah, 24. She has written about profound autism for many platforms, including The Atlantic, Psychology Today, Spectrum and Slate. Her most recent book is “Chasing the Intact Mind: How the Severely Autistic and Intellectually Disabled Were Excluded From the Debates That Affect Them Most” (2023). She is also the author of “We Walk: Life With Severe Autism” (2020) and “Each Day I Like It Better: Autism, ECT, and the Treatment of Our Most Impaired Children” (2014). She lives outside of Philadelphia with her husband and whichever of her five children happen to be home at the time.
Amy S.F. Lutz
Writer
From this contributor
Building bridges: Collaboration across the autism community
An autistic person and the mother of an autistic child explore partnership in the autism community.
Building bridges: Collaboration across the autism community
Adults with disabilities deserve right to choose where to live
The idea that one residential model is appropriate for the entire spectrum of intellectual and developmental disability is patently absurd.
Adults with disabilities deserve right to choose where to live
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”